159 related articles for article (PubMed ID: 7642171)
1. Protective effect of gamma-hydroxybutyrate and nicotinamide on low-dose streptozotocin-induced diabetes in mice.
Bouix O; Reynier M; Guintrand-Hugret R; Orsetti A
Horm Metab Res; 1995 May; 27(5):216-20. PubMed ID: 7642171
[TBL] [Abstract][Full Text] [Related]
2. Metabolic disturbances and defects in insulin secretion in rats with streptozotocin-nicotinamide-induced diabetes.
Szkudelski T; Zywert A; Szkudelska K
Physiol Res; 2013; 62(6):663-70. PubMed ID: 23869889
[TBL] [Abstract][Full Text] [Related]
3. Diabetic characteristics and alveolar bone loss in streptozotocin- and streptozotocin-nicotinamide-treated rats with periodontitis.
Kim JH; Lee DE; Choi SH; Cha JH; Bak EJ; Yoo YJ
J Periodontal Res; 2014 Dec; 49(6):792-800. PubMed ID: 24490978
[TBL] [Abstract][Full Text] [Related]
4. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
Portha B; Serradas P
Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
[TBL] [Abstract][Full Text] [Related]
5. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.
Masiello P; Cubeddu TL; Frosina G; Bergamini E
Diabetologia; 1985 Sep; 28(9):683-6. PubMed ID: 2933287
[TBL] [Abstract][Full Text] [Related]
7. [Establishment and application of the model of islet impaired by NO free radical released from streptozotocin].
Qian FY; Ouyang F; Fu DX; Ren TR
Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):349-52. PubMed ID: 15969020
[TBL] [Abstract][Full Text] [Related]
8. Transdifferentiation of both intra- and extra-islet cells into beta cells in nicotinamide treated neonatal diabetic rats: An in situ hybridization and double immunohistochemical study.
Kaya-Dagistanli F; Ozturk M
Acta Histochem; 2020 Oct; 122(7):151612. PubMed ID: 33066834
[TBL] [Abstract][Full Text] [Related]
9. Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model.
Szkudelski T
Exp Biol Med (Maywood); 2012 May; 237(5):481-90. PubMed ID: 22619373
[TBL] [Abstract][Full Text] [Related]
10. Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide.
Nakamura T; Terajima T; Ogata T; Ueno K; Hashimoto N; Ono K; Yano S
Biol Pharm Bull; 2006 Jun; 29(6):1167-74. PubMed ID: 16755011
[TBL] [Abstract][Full Text] [Related]
11. Pyridoxal 5' phosphate protects islets against streptozotocin-induced beta-cell dysfunction--in vitro and in vivo.
Kiran SG; Dorisetty RK; Umrani MR; Boindala S; Bhonde RR; Chalsani M; Singh H; Venkatesan V
Exp Biol Med (Maywood); 2011 Apr; 236(4):456-65. PubMed ID: 21464101
[TBL] [Abstract][Full Text] [Related]
12. Nicorandil improves diabetes and rat islet beta-cell damage induced by streptozotocin in vivo and in vitro.
Kasono K; Yasu T; Kakehashi A; Kinoshita N; Tamemoto H; Namai K; Ohno R; Ueba H; Kuroki M; Ishikawa S; Kawakami M
Eur J Endocrinol; 2004 Aug; 151(2):277-85. PubMed ID: 15296485
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of phosphodiesterase 3B in insulin-secreting cells of normal and streptozocin-nicotinamide-induced diabetic rats: implications for insulin secretion.
Zywert A; Szkudelska K; Szkudelski T
J Physiol Pharmacol; 2014 Jun; 65(3):425-33. PubMed ID: 24930515
[TBL] [Abstract][Full Text] [Related]
14. Diazoxide infusion at excess but not at basal hyperglycemia enhances beta-cell sensitivity to glucose in vitro in neonatally streptozotocin-diabetic rats.
Sako Y; Grill VE
Metabolism; 1992 Jul; 41(7):738-43. PubMed ID: 1535679
[TBL] [Abstract][Full Text] [Related]
15. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of a nicotinamide derivative, isonicotinamide, against streptozotocin-induced β-cell damage and diabetes in mice.
Fukaya M; Tamura Y; Chiba Y; Tanioka T; Mao J; Inoue Y; Yamada M; Waeber C; Ido-Kitamura Y; Kitamura T; Kaneki M
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):92-8. PubMed ID: 24246675
[TBL] [Abstract][Full Text] [Related]
17. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide.
Masiello P; Broca C; Gross R; Roye M; Manteghetti M; Hillaire-Buys D; Novelli M; Ribes G
Diabetes; 1998 Feb; 47(2):224-9. PubMed ID: 9519717
[TBL] [Abstract][Full Text] [Related]
18. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 receptor antagonist prevents low dose streptozotocin induced diabetes in mice.
Sandberg JO; Andersson A; Eizirik DL; Sandler S
Biochem Biophys Res Commun; 1994 Jul; 202(1):543-8. PubMed ID: 8037760
[TBL] [Abstract][Full Text] [Related]
20. Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE).
Shehata AM; Quintanilla-Fend L; Bettio S; Singh CB; Ammon HP
Phytomedicine; 2011 Sep; 18(12):1037-44. PubMed ID: 21831620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
